• 2004

Company Description

Anapa Biotech, formerly QuantiBact, is a biotech company developing molecular tools to enhance the performance of natural nucleic acids.

Anapa Biotech (formerly QuantiBact) is developing a technology that will significantly improve molecular diagnostics in the near future. Anapa Biotech is a biotech company founded on research regarding nucleic acid analogues performed at Syddansk Universitet and Hvidovre Hospital.